UWARN Investigators Awarded PHI Grant
Dr. Noelle Benzekri (Assistant Professor, Division of Allergy and Infectious Diseases) and Dr. Peter Rabinowitz (Professor, Depts. of Environmental/Occupational Health Sciences, Family Medicine, Global Health) have been awarded a Population Health Initiative Grant for their study, “The intersection of food security and Planetary Health in Senegal, West Africa: A mixed-methods pilot study”. Dr. Geoff Gottlieb (Professor, Division of Allergy and Infectious Diseases) is Co-Investigator. In collaboration with the non-profit organization, DIG, the findings from this study will be used to identify and develop interventions to improve food security, protect biodiversity, and promote environmental resilience in the region.
UWARN Co-Investigators Benzekri and Gottlieb lead International Epidemiology Databases to Evaluate AIDS in West Africa
Dr. Noelle Benzekri, assistant professor, is Program Lead for Sociobehavioral Research and Dr. Geoffrey Gottlieb, professor (Allergy and Infectious Diseases) is Co-Investigator for the NIH/NIAD funded U01 International Epidemiology Databases to Evaluate AIDS in West Africa (IeDEA-West Africa). In collaboration with colleagues at the University of Bordeaux and partners across West Africa, this study will use mixed-methods to evaluate cohorts of HIV and HIV-TB co-infected individuals in 8 countries: Benin, Burkina Faso, Cote d’Ivoire, Ghana, Mali, Nigeria, Senegal and Togo. The overarching goal of this study is to identify strategies to improve the HIV care cascade in the region. Dr. Benzekri will also be leading the new IeDEA-West Africa Food Insecurity Research Program.
Marta Giovanetti announced as 2021 "For Women in Science" laureate
L'Oréal Brasil, in partnership with UNESCO in Brazil and the Brazilian Academy of Sciences (ABC), has announced UWARN partner Marta Giovanetti of the Oswaldo Cruz Foundation (FIOCRUZ) as a laureate of the 2021 "For Women in Science" programme.
Detailed analysis by African scientists of SARS-CoV-2 published in Science; UWARN partner Prof Tulio de Oliveira senior author
Paper published in Science by a collaboration of researchers across Africa with UWARN partner Prof. Tulio de Oliveira as the senior author. The paper demonstrates the incredible efforts of 112 African and 25 international organizations monitoring the evolution of SARS-CoV-2 in Africa through a year of genomic surveillance.
2022 CREID Pilot Program
The 2022 Pilot Program timeline has been announced. Please see the link below for additional information.
UWARN PI Wes Van Voorhis to moderate WSAS Annual Symposium
UWARN PI Wes Van Voorhis will be moderating a session at the WSAS Annual Symposium on COVID-19: Science and Society on Thursday September 23, 2021 from 10AM-4PM. More information and registration below.
UWARN co-PIs Judith Wasserheit and Peter Rabinowitz supporting TIME magazine article
World Health Assembly to focus on ending COVID-19 pandemic and preparing for next one
UWARN PI co-author on variant immune evasion paper preprint
UWARN PI collaborates with other University of Washington researchers on a paper evaluating the SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
UWARN PI Wes Van Voorhis writes Op-Ed for Seattle Times
Wes Van Voorhis, UWARN Principle Investigator, writes Op-Ed for the Seattle Times on the rise of variants underscoring the importance of COVID-19 vaccination. The Op-Ed highlights the work on SARS-CoV-2 variants of UWARN partners Tulio de Oliveira, Luiz Carlos Junior Alcantara, and Marta Giovanetti.
UWARN Partner Tulio de Oliveira cited in NYT article on variant naming
UWARN Partner Michel Nussenzweig cited in New York Times article on B.1.526 SARS-CoV-2 variant
UWARN partner Tulio de Oliveira highlighted in NIH Director's Blog
UWARN highlighted in UW Department of Global Health news
UWARN highlighted in UW Department of Global Health news for the collaborative effort among UWARN partners to understand new SARS-CoV-2 variants and implications for vaccine efficacy.
UWARN Partner Tulio de Oliviera cited in New York Times
UWARN Partner Tulio de Oliviera of the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) at the University of KwaZulu-Natal cited in New York Times article on the evolving SARS-CoV-2 viruses and British lockdown